Promis Neurosciences Stock Analysis

ProMIS Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The book value of ProMIS Neurosciences was at this time reported as 4.27. The company recorded a loss per share of 20.0. ProMIS Neurosciences had not issued any dividends in recent years. The entity had 1:25 split on the 28th of November 2025. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Promis Neurosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To find out more about ProMIS Neurosciences contact the company at 416 847 6898 or learn more at https://www.promisneurosciences.com.

ProMIS Neurosciences Investment Alerts

ProMIS Largest EPS Surprises

View All Earnings Estimates

ProMIS Neurosciences Environmental, Social, and Governance (ESG) Scores

ProMIS Stock Institutional Investors

Note, although ProMIS Neurosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ProMIS Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 28.2 M.

ProMIS Profitablity

Management Efficiency

ProMIS Neurosciences has Return on Asset of (0.8538) % which means that on every $100 spent on assets, it lost $0.8538. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (3.558) %, meaning that it generated no profit with money invested by stockholders. ProMIS Neurosciences' management efficiency ratios could be used to measure how well ProMIS Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, ProMIS Neurosciences' Return On Tangible Assets are very stable compared to the past year. As of the 7th of February 2026, Return On Assets is likely to grow to 0.14, while Return On Capital Employed is likely to drop (0.95). At this time, ProMIS Neurosciences' Return On Assets are very stable compared to the past year.

Technical Drivers

As of the 7th of February, ProMIS Neurosciences holds the Semi Deviation of 6.02, risk adjusted performance of 0.075, and Coefficient Of Variation of 1217.92. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProMIS Neurosciences, as well as the relationship between them.

ProMIS Neurosciences Price Movement Analysis

ProMIS Neurosciences Insider Trading Activities

ProMIS Neurosciences Outstanding Bonds

ProMIS Neurosciences Predictive Daily Indicators

ProMIS Neurosciences Corporate Filings

ProMIS Neurosciences Forecast Models

ProMIS Neurosciences' time-series forecasting models are one of many ProMIS Neurosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ProMIS Neurosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ProMIS Neurosciences Bond Ratings

ProMIS Neurosciences financial ratings play a critical role in determining how much ProMIS Neurosciences have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ProMIS Neurosciences' borrowing costs.

ProMIS Neurosciences Debt to Cash Allocation

ProMIS Neurosciences has 2.42 M in debt with debt to equity (D/E) ratio of 1.08, which is OK given its current industry classification. ProMIS Neurosciences has a current ratio of 5.31, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. That said, strategic use of leverage may enable ProMIS to fund expansion initiatives and generate superior returns.

ProMIS Neurosciences Total Assets Over Time

ProMIS Neurosciences Assets Financed by Debt

The debt-to-assets ratio shows the degree to which ProMIS Neurosciences uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

ProMIS Neurosciences Debt Ratio

12.0

It appears that most of the ProMIS Neurosciences' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the ProMIS Neurosciences' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of ProMIS Neurosciences, which in turn will lower the firm's financial flexibility.

ProMIS Neurosciences Corporate Bonds Issued

ProMIS Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how ProMIS Neurosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ProMIS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ProMIS Neurosciences. By using and applying ProMIS Stock analysis, traders can create a robust methodology for identifying ProMIS entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ProMIS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ProMIS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ProMIS Neurosciences stock analysis indicators help investors evaluate how ProMIS Neurosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ProMIS Neurosciences shares will generate the highest return on investment. By understating and applying ProMIS Neurosciences stock analysis, traders can identify ProMIS Neurosciences position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

ProMIS Neurosciences's market price often diverges from its book value, the accounting figure shown on ProMIS's balance sheet. Smart investors calculate ProMIS Neurosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProMIS Neurosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between ProMIS Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProMIS Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.